Skip to main content

June 2017

Feature
06/14/2017
Abstract: Although clinical pathways are most often developed for very narrow diagnoses with limited pharmaceutical treatments, they are even more needed to provide direction for symptom management involving multiple...
Abstract: Although clinical pathways are most often developed for very narrow diagnoses with limited pharmaceutical treatments, they are even more needed to provide direction for symptom management involving multiple...
...
06/14/2017
Journal of Clinical Pathways

Feature

Perspectives
06/14/2017
Abstract: Since its passage in 2010, the Patient Protection and Affordable Care Act (ACA) has caused widespread disruption in the US health care ecosystem. This has put a huge spotlight on the system’s shortcomings,...
Abstract: Since its passage in 2010, the Patient Protection and Affordable Care Act (ACA) has caused widespread disruption in the US health care ecosystem. This has put a huge spotlight on the system’s shortcomings,...
...
06/14/2017
Journal of Clinical Pathways

Column

Clinical Pathways GPS
06/14/2017
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...
...
06/14/2017
Journal of Clinical Pathways

Insights

Interview
06/14/2017
JCP Editors
More than 10,000 children in the United States are diagnosed with cancer annually, according to data from the American Cancer Society.1 However, rates of survival in this younger patient population have risen...
More than 10,000 children in the United States are diagnosed with cancer annually, according to data from the American Cancer Society.1 However, rates of survival in this younger patient population have risen...
More...
06/14/2017
Journal of Clinical Pathways
Interview
06/14/2017
JCP Editors
The rising number of malpractice claims led against medical providers has captured the attention of both the medical community and the public. Discussions of malpractice management have centered around what steps...
The rising number of malpractice claims led against medical providers has captured the attention of both the medical community and the public. Discussions of malpractice management have centered around what steps...
The...
06/14/2017
Journal of Clinical Pathways

Department

Research in Review
06/14/2017
JCP Editors
Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...
Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...
...
06/14/2017
Journal of Clinical Pathways
Research in Review
06/14/2017
JCP Editors
Hematologic oncologists are hesitant to refer patients to hospice care due to their views of inadequate services offered there, according to study results published in Cancer (published online May 22, 2017;...
Hematologic oncologists are hesitant to refer patients to hospice care due to their views of inadequate services offered there, according to study results published in Cancer (published online May 22, 2017;...
...
06/14/2017
Journal of Clinical Pathways
Research in Review
06/14/2017
JCP Editors
Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...
Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...
...
06/14/2017
Journal of Clinical Pathways
Research in Review
06/14/2017
JCP Editors
A novel mechanism responsible for brain metastasis resistance to targeted therapy has been identified, which may help guide treatment strategies, according to a study published in Science Translational Medicine...
A novel mechanism responsible for brain metastasis resistance to targeted therapy has been identified, which may help guide treatment strategies, according to a study published in Science Translational Medicine...
A...
06/14/2017
Journal of Clinical Pathways
Research in Review
06/14/2017
JCP Editors
Perceptions of patients with cancer regarding secondary data use is essential to informing the implementation of oncology learning systems, according to research published in the Journal of Clinical Oncology...
Perceptions of patients with cancer regarding secondary data use is essential to informing the implementation of oncology learning systems, according to research published in the Journal of Clinical Oncology...
...
06/14/2017
Journal of Clinical Pathways